Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
European Society of Cardiology
Biotech
Cytokinetics’ ph. 3 cardio win sends stock soaring
Aficamten bested a standard-of-care beta blocker in a phase 3 heart disease test, bolstering the asset's blockbuster expectations.
Darren Incorvaia
Sep 2, 2025 2:05pm
At ESC 2025, researchers call for earlier, simpler TAVR
Aug 29, 2025 1:00pm
Philips, Siemens Healthineers push AI for heart ultrasound scans
Aug 29, 2023 1:13pm
Bayer, like its rivals, flops ph. 2 but hopes it made a splash
Aug 29, 2022 10:30am
